DCTD Programs
 |
Cancer Diagnosis Program Funds specimen resources and research to characterize tumors |
 |
 |
Radiation Research Program Funds novel radiotherapy research |
 |
Cancer Imaging Program Evaluates imaging in diagnosis, disease staging, and treatment monitoring |
|
 |
Translational Research Program Integrates scientific advancements in the understanding of the biology of human cancer |
 |
Cancer Therapy Evaluation Program Assesses new anticancer agents, radiation treatments, and surgical methods |
|
 |
Biometric Research Branch Provides statistical and biomathematical analyses |
 |
Developmental Therapeutics Program Funds drug discovery and development and provides related services |
|
 |
Office of Cancer Complementary and Alternative Medicine Improves the quality of cancer research on complementary and alternative modalities |
Message from the DCTD Director:
The Division of Cancer Treatment and Diagnosis (DCTD) focuses its activities on developing novel diagnostics and therapies for cancer. DCTD staff members, along with colleagues throughout the National Cancer Institute (NCI), academia, and industry, are working to generate More…
News
More Chemotherapy May Help after Initial Treatment for Childhood Leukemia Fails
FDA Acts to Bolster Supply of Critical Cancer Drugs
Clinical Trials Network Aims to Strengthen Cancer Immunotherapy Pipeline
Genetic abnormality predicts benefit from treatment for a rare brain tumor
Studies Highlight Complexities of Treating Advanced Head and Neck Cancer
Clinical Trials Point to New Options for Advanced Prostate Cancer
NCI’s Clinical Trials Cooperative Groups
National Meeting Report
DCTD Home | Text-onlyText and Graphics | Contact DCTD | Site Map | NCI Home | Accessibility | Policies | File Readers/Plug-ins
NIH… Turning Discovery Into Health